View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Carole Braudeau
  • Carole Braudeau

Credit Morning 04/24/2025

French retail sales down 2.4% in March + Q1 update|Fnac Darty: decent Q1 sales, strong performance in Southern Europe, guidance confirmed.|Saipem: good set of Q1 2025 results|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 24/04/2025

Baisse de 2,4% des ventes retail en France au mois de mars + point sur le T1|Fnac Darty : un CA T1 correct, bonne performance en Europe du Sud, guidances confirmées|Saipem: good set of Q1 2025 results|

Michael B. Schäfer ... (+2)
  • Michael B. Schäfer
  • Stephan Wulf
Dominic Rose ... (+2)
  • Dominic Rose
  • Naresh Chouhan

US Tariffs - Broad Tariffs are Highly Unlikely (7pgs)

Following a number of recent events, we discuss in this note what we think is the most likely outcome for the Pharma industry. We show that broad based tariffs on drugs are highly unlikely, that even if it were to happen, the impact of a 20% tariff is

Carole Braudeau
  • Carole Braudeau

Credit Morning 04/15/2025

Automotive: Trump raises possibility of reprieve on automotive tariffs|LVMH: disappointing Q1 sales|Bayer says glyphosate production could end|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 15/04/2025

Automobile : Trump évoque un possible sursis sur les droits de douane automobiles|LVMH : déception sur les ventes T1|Bayer says glyphosate production could end|

Carole Braudeau
  • Carole Braudeau

Credit Morning 04/10/2025

Eutelsat: the French State is weighing a capital increase (la Tribune)|Aema/Macif 's 2024 results show that the trajectory is well under way|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 10/04/2025

Eutelsat : Etat français réfléchirait à une augmentation de capital (la Tribune)|Aema /Macif a publié hier des résultats 2024 rassurants sur la trajectoire de la rentabilité|

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

S&P 500 and Nasdaq 100 Testing Prior 2022 Highs Since late-February (2/25/25 Compass) we expected an 8-10% pullback to provide a buying opportunity. But that all changed in last week's Compass (4/1/25), when we downgraded our outlook to bearish/cautious, citing several concerning developments (SPX and QQQ failure at 200-day MAs, bear flag breakdowns across major indexes targeting 5100-5200 on SPX, high yield spreads widening above 355bps, major tops on market leaders NVDA and META, semiconducto...

Carole Braudeau
  • Carole Braudeau

Credit Morning 04/07/2025

ams OSRAM: Moody’s cuts the rating to B3/stable from B2/negative|The possible sale of SFR is causing a stir in the telecoms sector (Le Figaro)|Groupama published an excellent set of FY2024 results|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 07/04/2025

ams OSRAM : Moody’s dégrade le rating de B2/négative à B3/stable|La possible vente de SFR met le secteur télécoms en effervescence (le Figaro)|Groupama a publié des résultats 2024 records|

Dominic Rose ... (+2)
  • Dominic Rose
  • Naresh Chouhan

US Tariffs - Transfer Pricing Could Negate Impact (6pgs)

We show that Big Pharma would not have to shift a single element of supply chain to the US and can mitigate most, if not all, of a 20% tariff on drugs, just by changing their transfer pricing strategy. In a scenario where the US corporation tax rate falls to 15% but tariffs are 20%, we show that Big Pharma profits would be unchanged, while the US government tax take would more than double. The losers would be low tax jurisdictions like Ireland, but they would get to keep their manufacturing base...

Abbvie Inc: 2 directors

Two Directors at Abbvie Inc sold/sold after exercising options/gave away 61,288 shares at between 0.000USD and 210.081USD. The significance rating of the trade was 79/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by al...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch